We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of GRNA yet.

GRNA Hedge Fund Activity: Q3 2023 in Review

0 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q3 2023, worth a combined $0 — down 100% from $9.16M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of GRNA and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.74M sold.

  • 0 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q3 2023, down from 48 in Q2 2023.
  • Funds reported $0 of GreenLight Biosciences Holdings, PBC Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q3 2023 and 48 closed out, a net change of -48 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q3 2023 was Cormorant Asset Management, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2023.